Unified Patent Court (UPC) analytics are now available. Check here

EP2931741

BOEHRINGER INGELHEIM ANIMAL HEALTH USA
Application Number
EP13814791A
Filing Date
Jan 15, 2014
Status
Revoked
Dec 20, 2019
Grant Date
Jul 25, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2931741B1 was granted on Jul 25, 2018 by Boehringer Ingelheim Animal Health USA The patent is currently Revoked.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

INTERVETApr 23, 2019 N/A

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2015158798
N/A
OppositionWO2016097245
N/A
OppositionUS2017058266
N/A
OppositionWO2018083154
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.